Caspase inhibitor BD-fmk distinguishes transforming growth factor β- induced apoptosis from growth inhibition

Cell Growth and Differentiation

Volumn 9, Issue 10, 1998, Pages 869-875

  Brown, Thomas L ^a   Patil, Supriya ^a   Basnett, Robert K ^a   Howe, Philip H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; ENZYME ACTIVITY; GROWTH INHIBITION; GROWTH REGULATION; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CASPASES; CELL DIVISION; CYSTEINE PROTEINASE INHIBITORS; DNA; DNA FRAGMENTATION; G1 PHASE; IN SITU NICK-END LABELING; MICE; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031660873     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Sasaki, H., Pollard, R. B., Schmitt, D., and Suzuki, F. Transforming growth factor-β in the regulation of the immune response. Clin. Immunol. Immunopathol., 65: 1-9, 1992.
2. Wahl, S. M., Hunt, D. A., Wong, H. L., Dougherty, S., McCartney-Francis, N., Wahl, L. M., Ellingsworth, L., Schmidt, J. A., Hall, G., Roberts, A. B., and Sporn, M. B. Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol., 140: 3026-3032, 1988.
3. Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B., and Fauci, A. S. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol., 137: 3855-3860, 1986.
4. Lomo, J., Blomhoff, H. K., Beiske, K., Stokke, T., and Smeland, E. B. TGF-β 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J. Immunol., 154: 1634-1643, 1995.
5. Warner, G. L., Ludlow, J. W., Nelson, D. A., Gaur, A., and Scott, D. W. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor-β but pRB hypophosphorylation is transforming growth factor β-independent. Cell Growth Differ., 3: 175-181, 1992.
6. Chaouchi, N., Arvanitakis, L., Auffredou, M. T., Blanchard, D. A., Vazquez, A., and Sharma, S. Characterization of transforming growth factor-β 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene, 11: 1615-1622, 1995.
7. Letterio, J. J., Geiser, A. G., Kulkarni, A. B., Dang, H., Kong, L., Nakabayashi, T., Mackall, C. L., Gress, R. E., and Roberts, A. B. Autoimmunity associated with TGF-β1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest., 98: 2109-2119, 1996.
8. Letterio, J. J., and Roberts, A. B. TGF-β: a critical modulator of immune cell function. Clin. Immunol. Immunopathol., 84: 244-250, 1997.
9. Diebold, R. J., Eis, M. J., Yin, M., Ormsby, I., Boivin, G. P., Darrow, B. J., Saffitz, J. E., and Doetschman, T. Early-onset multifocal inflammation in the transforming growth factor β 1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. USA, 92: 12215-12219, 1995.
10. Dang, H., Geiser, A. G., Letterio, J. J., Nakabayashi, T., Kong, L., Fernandes, G., and Talal, N. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-β knockout mice. J. Immunol., 155: 3205-3212, 1995.
11. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziation, N., and Doetschman, T. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature (Lond.), 359: 693-699, 1992.
12. Talil, N., and Bunim, J. J. The development of malignant lymphoma in the course of Sjögren's syndrome. Am. J. Med., 36: 529, 1964.
13. Arsura, M., Wu, M., and Sonenshein, G. E. TGF β 1 inhibits NF-κ B/Rel activity inducing apoptosis of B cells: transcriptional activation of I κ B α. Immunity, 5: 31-40, 1996.
14. Gottschalk, A. R., and Quintans, J. Apoptosis in B lymphocytes. The WEHI-231 perspective. Immunol. Cell Biol., 73: 8-16, 1995.
15. 1-S-phase growth arrest. Mol. Cell. Biol., 11: 1185-1194, 1991.
16. Laiho, M., De Caprio, J. A., Ludlow, J. W., Livingston, D. M., and Massague, J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell, 62: 175-185, 1990.
17. Fischer, G., Kent, S. C., Joseph, L., Green, D. R., and Scott, D. W. Lymphoma models for B cell activation and tolerance. X. Anti-μ-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J. Exp. Med., 179: 221-228, 1994.
18. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
19. Ewen, M. E., Sluss, H. K., Whitehouse, L. L., and Livingston, D. M. TGF β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell, 74: 1009-1020, 1993.
20. 1 growth arrest of murine B-cell lymphomas. Mol. Biol. Cell, 7: 553-564, 1996.
21. Hocevar, B. A., and Howe, P. H. Mechanisms of TGF-B-induced cell cycle arrest. Miner. Electrolyte Metab., 24: 131-135, 1998.
22. Monroe, J. G. Tolerance sensitivity of immature-stage B cells. Can developmentally regulated B cell antigen receptor (BCR) signal transduction play a role? J. Immunol., 156: 2657-2660, 1996.
23. Goodnow, C. C. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA, 93: 2264-2271, 1996.
24. White, E. Life, death, and the pursuit of apoptosis. Genes Dev., 10: 1-15, 1996.
25. Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., Chapman, K. T., and Nicholson, D. W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem., 272: 17907-17911, 1997.
26. Salvesen, G. S., and Dixit, V. M. Caspases: intracellular signaling by proteolysis. Cell, 97: 443-446, 1997.
27. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem. J., 326: 1-16, 1997.
28. Chen, R. H., and Chang, T. Y. Involvement of caspase family proteases in transforming growth factor-β-induced apoptosis. Cell Growth Differ., 8: 821-827, 1997.
29. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
30. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
31. Brown, T. L., Fischer, W. C., Collins, M. D., De, B. K., and Scott, W. J., Jr. Identification of a 100-kDa phosphoprotein in developing mouse embryos as elongation factor 2. Arch. Biochem. Biophys., 309: 105-110, 1994.
32. Lee, H., Arsura, M., Wu, M., Duyao, M., Buckler, A. J., and Sonenshein, G. E. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med., 181: 1169-1177, 1995.
33. Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., Fitz Gerald, M. J., Rothstein, T. L., Sherr, D. H., and Sonenshein, G. E. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J., 15: 4682-4690, 1996.
34. Wu, M., Yang, W., Bellas, R. E., Schauer, S. L., Fitz Gerald, M. J., Lee, H., and Sonenshein, G. E. c-myc promotes survival of WEHI 231 B lymphoma cells from apoptosis. Curr. Top. Microbiol. Immunol., 224: 91-101, 1997.
35. Wu, M., Arsura, M., Bellas, R. E., Fitz Gerald, M. J., Lee, H., Schauer, S. L., Sherr, D. H., and Sonenshein, G. E. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol. Cell. Biol., 16: 5015-5025, 1996.
36. Nicholson, D. W., and Thornberry, N. A. Caspases: killer proteases. Trends Biochem. Sci., 22: 299-306, 1997.
37. Mashima, T., Naito, M., Kataoka, S., Kawai, H., and Tsuruo, T. Aspartate-based inhibitor of interleukin-1 β-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem. Biophys. Res. Commun., 209: 907-915, 1995.
38. Naito, M., Nagashima, K., Mashima, T., and Tsuruo, T. Phosphatidylserine externalization is a downstream event of interleukin-1 β-converting enzyme family protease activation during apoptosis. Blood, 89: 2060-2066, 1997.
39. McCarthy, N. J., Whyte, M. K., Gilbert, C. S., and Evan, G. I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol., 136: 215-227, 1997.
40. 1 phase cyclin dependent kinases by transforming growth factor β 1. J. Cell. Biochem., 56: 418-425, 1994.
41. Gottschalk, A. R., Joseph, L. J., and Quintans, J. Differential induction of Egr-1 expression in WEHI-231 sublines does not correlate with apoptosis. Eur. J. Immunol., 23: 2011-2015, 1993.
42. Benhamou, L. E., Watanabe, T., Kitamura, D., Cazenave, P. A., and Sarthou, P. Signaling properties of anti-immunoglobulin-resistant variants of WEHI-231 B lymphoma cells. Eur. J. Immunol., 24: 1993-1999, 1994.
43. Hartley, S. B., Cooke, M. P., Fulcher, D. A., Harris, A. W., Cory, S., Basten, A., and Goodnow, C. C. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested developed and cell death. Cell, 72: 325-335, 1993.
44. Letterio, J. J., Geiser, A. G., Kulkarni, A. B., Roche, N. S., Sporn, M. B., and Roberts, A. B. Maternal rescue of transforming growth factor-β 1 null mice. Science (Washington DC), 264: 1936-1938, 1994.